Upstream Bio, Inc.
NASDAQ:UPBBiotechnology
+$0.10 today
- Market cap
- $114.01M
- Beta
- 1.11
- P/E (TTM)
- -2.2
- EPS (TTM)
- -$2.89
Volume 1.24M
Average 0.66M
UPB Property, Plant & Equipment (Net)
Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.
Upstream Bio, Inc.NASDAQ: UPB
Property, Plant & Equipment (Net) · Q1 FY2026 · quarter ended Mar 2026
Property, plant & equipment (net) falls 27.7% from a year ago
Property, plant & equipment (net) stood at $1.58M at the end of Q1 FY2026, down 27.7% from a year earlier and down 11.2% from the prior quarter. Over 3 fiscal years it compounded at +121.4% a year.
Context
- Property, plant & equipment (net) amounted to 0.5% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Property, plant & equipment (net) increased in 2 of the last 3 fiscal years.
What to watch
Whether property, plant & equipment (net) keeps falling in the next quarterly balance sheet after a -27.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Property, Plant & Equipment (Net) history
USD · from the balance sheet
- Latest · FY2025
- 1.78M USD
- Year-over-year change
- -24.7%
- 3-year CAGR
- +121.4%
| Period | Period end | Property, Plant & Equipment (Net) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.78M | -24.7% |
| FY2024 | 2024-12-31 | 2.37M | +1070.8% |
| FY2023 | 2023-12-31 | 202K | +23.2% |
| FY2022 | 2022-12-31 | 164K | — |
Property, Plant & Equipment (Net) vs competitors
How UPB compares with its peers on the latest reported figures
- Peers report in different currencies, so property, plant & equipment (net) is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -27.7% is the 6th highest of 9, against a peer median of -23.7%.
- Property, plant & equipment (net) amounts to 0.5% of total assets for UPB, versus a peer median of 0.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $113.06M USD | -40.5% | -8.4% | 14.9% | |
| Mar 2026 | $63.51M USD | -78.2% | -44.7% | 6.1% | |
| Jun 2026 | $38.04M USD | -17.6% | -17.9% | 3.9% | |
| Mar 2026 | $18.07M USD | -30.9% | -23.4% | 3.1% | |
| Sep 2026 | $4.44M USD | -24.4% | -12.3% | 0.6% | |
UPBUpstream Bio, Inc. | Mar 2026 | $1.58M USD | -27.7% | +121.4% | 0.5% |
| Mar 2026 | $1.39M USD | -22.9% | +12.9% | 0.3% | |
| Mar 2026 | $1.12M USD | -12.4% | -8.3% | 0.1% | |
| Sep 2026 | €1.11M EUR | -11.3% | +30.7% | 0.4% | |
| Sep 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding UPB) | — | -23.7% | -10.4% | 0.6% | |
Competitors are the stored peer set for UPB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Upstream Bio, Inc.
NASDAQ:UPB
Intrinsic Alpha fair value
Locked
Current Price
$2.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.